TickerFactsScreenerDevelopers

Viking Therapeutics, Inc. (VKTX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2013: $179.6K2014: $755.9K2015: $768.5K2016: $3.08M2017: $8.99M2018: $24.78M2019: $8.38M2020: $29.12M2021: $26.37M2022: $36.63M2023: $55.52M2024: $26.68M2025: $165.81M$165.81M
2013Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$165.81M+521.6%
2024$26.68M-51.9%
2023$55.52M+51.6%
2022$36.63M+38.9%
2021$26.37M-9.4%
2020$29.12M+247.6%
2019$8.38M-66.2%
2018$24.78M+175.7%
2017$8.99M+192.2%
2016$3.08M+300.2%
2015$768.5K+1.7%
2014$755.9K+320.8%
2013$179.6K—